Neurocrine Biosciences (NBIX) Prepaid Assets (2010 - 2026)

Neurocrine Biosciences' Prepaid Assets history runs 17 years deep, the most recent figure standing at $224.8 million for Q1 2026.

• Quarterly Prepaid Assets rose 88.43% year-over-year to $224.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $224.8 million (up 88.43% YoY) and the FY2025 annual result came in at $170.7 million, up 168.4% from the prior year.
• Prepaid Assets was $224.8 million for Q1 2026 at Neurocrine Biosciences, up from $170.7 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $224.8 million in Q1 2026 and bottomed at $60.8 million in Q1 2022.
• A 5-year average of $105.9 million and a median of $100.6 million in 2023 frame the typical range for Prepaid Assets.
• Peak annual rise in Prepaid Assets reached 168.4% in 2025, while the deepest fall reached 43.96% in 2025.
• Neurocrine Biosciences' Prepaid Assets stood at $79.1 million in 2022, then advanced by 23.64% to $97.8 million in 2023, then slumped by 34.97% to $63.6 million in 2024, then surged by 168.4% to $170.7 million in 2025, then soared by 31.69% to $224.8 million in 2026.
• Business Quant data shows NBIX's Prepaid Assets at $224.8 million in Q1 2026, $170.7 million in Q4 2025, and $68.2 million in Q3 2025.